FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Gross Profit 2020–2025
FibroGen, Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- FibroGen, Inc. gross profit for the quarter ending March 31, 2026 was -368000, a 114.80% decrease year-over-year.
- FibroGen, Inc. gross profit for the twelve months ending March 31, 2026 was 3.0 M.
- FibroGen, Inc. annual gross profit for 2025 was 5.9 M, a 58.15% decrease from 2024.
- FibroGen, Inc. annual gross profit for 2024 was 14.1 M, a 89.09% decrease from 2023.
- FibroGen, Inc. annual gross profit for 2023 was 128.9 M, a 7.02% increase from 2022.
- FibroGen, Inc. annual gross profit for 2022 was 120.5 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
FibroGen, Inc. Gross Profit — FAQ
FibroGen, Inc. (KYNB) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is FibroGen, Inc.'s gross profit?
FibroGen, Inc. (KYNB) reported gross profit of $6M for fiscal 2025.
Where can I see KYNB's gross profit history?
The chart and table above show FibroGen, Inc.'s gross profit by year and by quarter, including the growth rate.